Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus
Shuofeng Yuan(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Dong‐Yan Jin(University of Hong Kong), Lei Wen(Queen Mary Hospital), Hin Chu(HKU-Pasteur Research Pole), Jasper Fuk‐Woo Chan(Hong Kong Baptist University), Terance Gi‐Wai Tsang(University of Hong Kong), Jianli Cao(University of Hong Kong), Jian‐Piao Cai(University of Hong Kong), Garnet Kwan-Yue Choi(University of Hong Kong), Zi‐Wei Ye(Harbin University of Science and Technology), Jingjing Huang(University of Hong Kong), Mifang Liang(Chinese Center For Disease Control and Prevention), Chris Chun-Yiu Chan(University of Hong Kong), Kenn Ka‐Heng Chik(University of Hong Kong), Feifei Yin(Chinese Academy of Sciences)
Cited by 40
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k